Intravenous rituximab versus oral mycophenolate mofetil in sustaining remission of calcineurin inhibitor dependent steroid resistant nephrotic syndrome: An open label randomized controlled trial

被引：0
|
作者：
Sinha, Aditi [1 ]
Meena, Jitendra [1 ]
Yadav, Menka [1 ]
Hari, Pankaj [1 ]
Bagga, Arvind [1 ]
机构：
[1] All India Inst Med Sci, Pediat, New Delhi, India
来源：
PEDIATRIC NEPHROLOGY | 2024年 / 39卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
1330
引用
收藏
页码：S243 / S243
页数：1
相关论文
共 50 条
  • [41] Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JS']JSKDC07)
    Horinouchi, Tomoko
    Sako, Mayumi
    Nakanishi, Koichi
    Ishikura, Kenji
    Ito, Shuichi
    Nakamura, Hidefumi
    Oba, Mari Saito
    Nozu, Kandai
    Iijima, Kazumoto
    BMC NEPHROLOGY, 2018, 19
  • [42] Comparison of Mycophenolate Mofetil Plus Methotrexate versus Cyclophosphamide with Sequential Azathioprine for Active Takayasu's Arteritis: An Open-Label, Randomized-Controlled Trial
    Sun, Xiaochuan
    Li, Jing
    Duan, Xinwang
    Zhang, Liyun
    Yao, Dongyun
    Xue, Jing
    Wu, Zhenbiao
    Zhao, Yi
    Wu, Lijun
    Zhang, Hongfeng
    Li, Mengtao
    Zeng, Xiaofeng
    Merkel, Peter
    Tian, Xinping
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3460 - 3462
  • [43] THERAPEUTIC PLASMA EXCHANGE VERSUS INTRAVENOUS IMMUNOGLOBULIN IN CHILDREN WITH SEVERE GUILLAIN BARRE SYNDROME - AN OPEN LABEL, RANDOMIZED CONTROLLED TRIAL
    Randhawa, M. S.
    Bansal, A.
    Jayashree, M.
    Sharma, R.
    Sankhyan, N.
    Hans, R.
    Nallasamy, K.
    Angurana, S.
    PEDIATRIC CRITICAL CARE MEDICINE, 2022, 23 (11)
  • [44] Rituximab for Adult-Onset Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome: A Multicenter, Double-Blind, Randomized, Placebo Controlled Trial
    Isaka, Yoshitaka
    Maruyama, Shoichi
    Sakaguchi, Mika
    Hayashi, Hiroki
    Kaida, Yusuke
    Goto, Shin
    Tsukamoto, Tatsuo
    Maeshima, Akito
    Ikeda, Yoichiro
    Sakai, Norihiko
    Sawa, Naoki
    Furuichi, Kengo
    Yamagata, Kunihiro
    Sakaguchi, Yusuke
    Shinzawa, Maki
    Wada, Takehiko
    Shibagaki, Yugo
    Hiromura, Keiju
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [45] Trial Role of Mycophenolate Mofetil (MMF) in Steroid Nonresponsive Severe Acute Alcoholic Hepatitis: A Randomized, Open-Label, Placebo-Controlled Prospective Clinical Pilot Trial-MASH
    Basu, Patrick
    Shah, Niraj
    Aloysius, Mark
    Brown, Robert
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S176 - S176
  • [46] A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey)
    Shibasaki T.
    Koyama A.
    Hishida A.
    Muso E.
    Osawa G.
    Yamabe H.
    Shiiki H.
    Makino H.
    Sato H.
    Ishikawa I.
    Maeda K.
    Tomita K.
    Arakawa M.
    Ishida M.
    Sato M.
    Nagase M.
    Kashihara N.
    Yorioka N.
    Koike T.
    Saito T.
    Harada T.
    Mitarai T.
    Sugisaki T.
    Nagasawa T.
    Tomino Y.
    Nojima Y.
    Kobayashi Y.
    Sakai O.
    Journal of Clinical and Experimental Nephrology, 2004, 8 (2): : 117 - 126
  • [47] Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial
    Ke Zhao
    Ren Lin
    Zhiping Fan
    Xiaoyong Chen
    Yu Wang
    Fen Huang
    Na Xu
    Xi Zhang
    Xin Zhang
    Li Xuan
    Shunqing Wang
    Dongjun Lin
    Lan Deng
    Danian Nie
    Jianyu Weng
    Yonghua Li
    Xiaohui Zhang
    Yuhua Li
    A. P. Xiang
    Qifa Liu
    Journal of Hematology & Oncology, 15
  • [48] Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial
    Zhao, Ke
    Lin, Ren
    Fan, Zhiping
    Chen, Xiaoyong
    Wang, Yu
    Huang, Fen
    Xu, Na
    Zhang, Xi
    Zhang, Xin
    Xuan, Li
    Wang, Shunqing
    Lin, Dongjun
    Deng, Lan
    Nie, Danian
    Weng, Jianyu
    Li, Yonghua
    Zhang, Xiaohui
    Li, Yuhua
    Xiang, A. P.
    Liu, Qifa
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [49] Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial
    Yadav, Menka
    Sinha, Aditi
    Khandelwal, Priyanka
    Hari, Pankaj
    Bagga, Arvind
    PEDIATRIC NEPHROLOGY, 2019, 34 (05) : 829 - 835
  • [50] Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial
    Menka Yadav
    Aditi Sinha
    Priyanka Khandelwal
    Pankaj Hari
    Arvind Bagga
    Pediatric Nephrology, 2019, 34 : 829 - 835
12345